{"entity":{"id":"nct06301386","kind":"trial","name":"Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients","aka":[],"tldr":"A phase 2 trial of everolimus in colorectal cancer, run by Fudan University, not yet recruiting.","summary":"Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients is a phase 2, interventional study registered as NCT06301386 by Fudan University, with a registry enrolment figure of 25 participants, started 2024-04-01 and due to reach its primary completion in 2026-05-01. Interventions recorded: Everolimus; PD-1. Conditions listed: Colon Cancer. Primary outcome: objective response rate (ORR). Colorectal eligibility wording from the registry: \"Patients with histologically or cytologically confirmed locally advanced and advanced colorectal cancer that cannot be R0 resected;\". Sites: China. No results are recorded here; the registry entry is the source.","status":"planned","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT06301386","url":"https://clinicaltrials.gov/study/NCT06301386"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["colon-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["everolimus"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06301386","phase":"2","setting":"The Combination of Everolimus and PD-1 in the Treatment of Locally Advanced and Advanced Colorectal Cancer That Cannot be R0 Resected","sponsor":"Fudan University","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06301386/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"}],"drug":[{"id":"everolimus","kind":"drug","name":"Everolimus","route":"/drugs/everolimus/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}